
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
A leading biotech company in Hamburg is seeking an exceptional Scientist to lead efforts in the identification of novel therapeutic antibodies. This role involves expertise in flow cytometry, focusing on high-throughput screening of hybridomas. The ideal candidate holds a PhD and has solid experience in immunology and cancer biology. Join a fast-growing team that values innovation and offers numerous benefits including flexible hours and courses in German and English.
I Indivumed is a biotech company focusing on precision oncology. For almost 25 years we have been driven by a single overarching vision : a world in which precision therapy offers a cure for every cancer patient.
Specialized in early drug discovery our R&D approach is based on the belief that we need to fundamentally understand the disease to gain novel insights and develop effective therapeutics. To do so we start with carefully collected and curated patient samples resulting in a comprehensive and proprietary database. By employing advanced biomathematical and bioinformatic methods on this excellent data we discover therapeutically novel targets. From our high-quality tissue we generate patient-derived 2D and 3D cellular models allowing us to perform target validation and therapeutic development in an environment that is as close to the patient as possible.
Drive dedication and our shared purpose make us who we are.
Driven by our pioneering spirit and our shared purpose we explore the complexity of cancer with curiosity and determination. Thriving on innovation we value unique perspectives and visionary scientific approaches to grow together. Whether as a scientist as a data analyst or in a corporate function everyone contributes to our common goal.
If you thrive on discovery come join our team and make your impact!
We are looking for an exceptional Scientist to lead our efforts in the identification and characterization of novel therapeutic antibodies. You will be the subject matter expert for flow cytometry responsible for standardizing executing and analyzing high-throughput screening of hybridomas targeting critical cancer surface proteins.